Alfredo Nicosia Selected Research

Malaria

1/2020	New viral vectors for infectious diseases and cancer.
1/2018	Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.
6/2017	Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.
1/2017	Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.
8/2016	Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.
1/2016	Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
5/2015	Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.
4/2015	Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
3/2015	Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.
1/2015	Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfredo Nicosia Research Topics

Disease

40	Infections 11/2021 - 10/2003
24	Malaria 01/2020 - 02/2006
23	Neoplasms (Cancer) 12/2021 - 01/2008
15	Vaccinia 11/2021 - 05/2014
6	Persistent Infection 08/2016 - 04/2003
5	Chronic Hepatitis C 11/2021 - 02/2012
5	Viremia 04/2017 - 02/2006
5	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2014 - 12/2011
4	Bites and Stings (Sting) 01/2021 - 12/2012
4	Reinfection 08/2016 - 11/2014
3	Herpes Simplex 01/2021 - 01/2020
3	Carcinoma (Carcinomatosis) 01/2018 - 10/2003
3	Hepatitis C 05/2016 - 06/2008
3	Hepatocellular Carcinoma (Hepatoma) 02/2012 - 10/2002
2	Rabies (Hydrophobia) 04/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 05/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2013
2	Disease Progression 09/2019 - 07/2012
2	Injection Site Reaction 01/2017 - 08/2015
2	Respiratory Tract Infections (Respiratory Tract Infection) 08/2015 - 01/2015
2	Liver Diseases (Liver Disease) 11/2014 - 02/2012
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Smallpox (Variola) 01/2020
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2020
1	Microsatellite Instability 01/2020
1	Melanoma (Melanoma, Malignant) 09/2019
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2018
1	Coinfection 01/2018
1	Polyps 01/2018
1	Turcot syndrome 01/2018
1	Papillomavirus Infections 02/2017
1	Ebola Hemorrhagic Fever 01/2017
1	Vesicular Stomatitis 04/2016
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2016

Drug/Important Bio-Agent (IBA)

47	VaccinesIBA 11/2021 - 02/2006
24	AntigensIBA 08/2021 - 02/2009
20	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2003
10	Antiviral Agents (Antivirals)IBA 01/2021 - 02/2012
9	Monoclonal AntibodiesIBA 01/2015 - 10/2002
8	AntibodiesIBA 10/2018 - 08/2007
8	EpitopesIBA 01/2018 - 09/2005
6	Neutralizing AntibodiesIBA 01/2020 - 05/2014
5	Glycoproteins (Glycoprotein)IBA 01/2020 - 10/2002
5	ThrombospondinsIBA 01/2018 - 01/2013
4	Peptides (Polypeptides)IBA 08/2021 - 01/2012
4	Biological ProductsIBA 01/2021 - 01/2008
4	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2017
4	Scavenger Receptors (Scavenger Receptor)IBA 11/2014 - 10/2003
3	RNA (Ribonucleic Acid)IBA 11/2021 - 07/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 01/2019
3	InterferonsIBA 01/2021 - 11/2014
3	Malaria VaccinesIBA 01/2016 - 12/2012
2	Pharmaceutical PreparationsIBA 11/2021 - 01/2015
2	Interleukin-12 (IL 12)IBA 12/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 04/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 10/2012
2	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2016 - 05/2015
2	Tight Junction ProteinsIBA 01/2016 - 01/2015
2	Antimalarials (Antimalarial Agents)IBA 01/2016 - 05/2015
2	Claudin-1IBA 01/2016 - 01/2015
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 04/2015 - 01/2013
2	Recombinant ProteinsIBA 12/2014 - 01/2012
2	Adenovirus VaccinesIBA 05/2014 - 05/2014
2	Subunit VaccinesIBA 01/2013 - 12/2010
2	Merozoite Surface Protein 1 (MSA1)IBA 12/2012 - 12/2011
2	Lipoproteins (Lipoprotein)IBA 01/2010 - 08/2007
2	HDL LipoproteinsIBA 08/2007 - 10/2003
1	Adenosine Triphosphate (ATP)IBA 12/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2021
1	Adenosine DeaminaseIBA 12/2021
1	Adenosine (Adenocard)FDA LinkGeneric 12/2021
1	Drug CombinationsIBA 11/2021
1	bempegaldesleukinIBA 11/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	MesothelinIBA 01/2021
1	NectinsIBA 01/2021
1	CytokinesIBA 12/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2020
1	Interferon Type IIBA 11/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2020
1	IpilimumabIBA 08/2020
1	LigandsIBA 08/2020
1	Cancer VaccinesIBA 01/2020
1	SolutionsIBA 01/2020
1	SurvivinIBA 01/2020
1	atezolizumabIBA 11/2019
1	Caspase 3 (Caspase-3)IBA 11/2019
1	Illicit Drugs (Recreational Drugs)IBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Papillomavirus Vaccines (HPV Vaccines)IBA 02/2017
1	Artificial ReceptorsIBA 01/2017
1	human ERBB2 proteinIBA 01/2017
1	Viral ProteinsIBA 12/2016

Therapy/Procedure

9	Therapeutics 11/2021 - 02/2012
4	Immunotherapy 12/2021 - 02/2006
4	Liver Transplantation 01/2015 - 02/2012
1	Radiotherapy 09/2019